+++J. Med. Chem

[Татка]

Помогите, пожалуйста:
1)Central serotonin receptors as targets for drug research
Richard A. Glennon
J. Med. Chem., 1987, 30 (1), pp 1–12
DOI:

DOI:

http://dx.doi.org/10.1021/jm00384a001

2)Binding of Arylpiperazines, (Aryloxy)propanolamines, and Tetrahydropyridylindoles to the 5-HT1A Receptor: Contribution of the Molecular Lipophilicity Potential to Three-Dimensional Quantitative Structure−Affinity Relationship Models
Patrick Gaillard, Pierre-Alain Carrupt, Bernard Testa,* and Philippe Schambel†
J. Med. Chem., 1996, 39 (1), pp 126–134
DOI:

DOI:

http://dx.doi.org/10.1021/jm950410b

3)1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents
John A. Lowe III, Thomas F. Seeger, Arthur A. Nagel, Harry R. Howard, Patricia A. Seymour, James H. Heym, Frank E. Ewing, Michael E. Newman, Anne W. Schmidt,
J. Med. Chem., 1991, 34 (6), pp 1860–1866
DOI:

DOI:

http://dx.doi.org/10.1021/jm00110a016

4)N4-Unsubstituted N1-Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands
Wilma Kuipers, Ineke van Wijngaarden, Chris G. Kruse, Marian ter Horst van Amstel, Martin Th. M. Tulp, Adriaan P. IJzerman
J. Med. Chem., 1995, 38 (11), pp 1942–1954
DOI:

DOI:

http://dx.doi.org/10.1021/jm00011a014

[eFo]

[Татка]

Спасибо огромное